Patents Update

Summary by AI BETAClose X

Gelion PLC has announced the successful grant of six patents, including three in the United States, which strengthen the intellectual property protection for its sulfur battery technology and support its commercialisation strategy in key global markets. These patents cover innovations in thermal management, cathode-electrolyte design, and anode protection for the Group's Lithium-Sulfur technology, enhancing battery safety, performance, and lifespan. This expanded IP portfolio, which protects the entire Li-S battery value chain, aims to provide partners with greater confidence in integrating Gelion's Nano-Encapsulated Sulfur (NES™) cathode material, a low-cost alternative to critical minerals used in current lithium-ion batteries.

Disclaimer*

Gelion PLC
23 September 2026
 

23 September 2026

 

Gelion plc

(“Gelion”, “Company” or the “Group”)

 

Successful Grant of Six Patents, Including Three in the U.S.

 

Patent grants strengthen protection for Gelion’s sulfur battery technology and support commercialisation across key global markets

 

Gelion is seeking to replace the critical minerals in current lithium-ion battery cathodes with its Nano-Encapsulated Sulfur (NES™), a low-cost cathode active material made from abundantly available sulfur, that can be deployed within existing global manufacturing lines.

 

Gelion plc (AIM: GELN), the sulfur battery technology company, is pleased to announce the grant of six patents: three in the United States, two in Europe and one in Asia. The patents protect innovations in thermal management, cathode-electrolyte design and anode protection relating to the Group’s Lithium-Sulfur (“Li-S”) technology.

 

These grants further strengthen Gelion’s intellectual property position globally, particularly in the United States, as the Group advances its U.S. market entry and commercialisation strategy.

 

Gelion’s IP portfolio provides end-to-end protection across the Li-S battery value chain, covering the anode, cathode, electrolyte, battery design and manufacturing, and battery management. This breadth of protection supports collaborative development and commercial deployment by giving existing and prospective partners greater confidence in Gelion’s technology proposition.

 

The three U.S. patents align directly with the Group’s development roadmap and protect distinct advancements in thermal management, cathode-electrolyte design and anode protection. These advancements contribute to:

 

  • enhancement of battery safety and thermal management;
  • improvement of cycling performance and cell lifespan; and
  • greater cathode stability during extended cycling.

 

Aligned with Gelion’s commercialisation strategy

Gelion’s strategy is to establish its sulfur cathode technology as an alternative to incumbent cathode technologies and commercialise it through a capital-light partnership model. The Group is developing its sulfur cathode material for integration by cell manufacturers across multiple cell configurations and applications.

 

The newly granted patents extend protection beyond Gelion’s core cathode active material to complementary cell-level technologies, strengthening its proposition to battery manufacturers by reducing integration and intellectual property risk and supporting adoption within global supply chains and strategically important applications.

 

Matt Wood, Gelion CEO, commented: “Securing these patents is an important milestone in strengthening the intellectual property around our sulfur cathode platform. By extending protection into complementary cell-level technologies, we can give our current and prospective partners greater confidence to evaluate and integrate Gelion’s technology, supporting its adoption across strategically important applications and markets.”

 

For more information, please visit Next-Generation Sulfur Battery Technologies | Gelion or contact:

 

Gelion plc
Matt Wood, CEO
Amit Gupta, CFO

 

via Tavistock

Strand Hanson Limited (Nominated and Financial Adviser)
Christopher Raggett / Rob Patrick / Harry Marshall

+44 (0) 20 7409 3494

Oberon Capital (Joint Broker)
Nick Lovering / Mike Seabrook / Adam Pollock

 

+44 (0) 20 3179 5300

Allenby Capital Limited (Joint Broker)

Jos Pinnington / Lauren Wright (Sales and Corporate Broking)

Alex Brearley / Ashur Joseph (Corporate Finance)

 

+44 (0) 20 3328 5656

Tavistock (Financial & Corporate PR)
Simon Hudson / Nick Elwes / Saskia Sizen

+44 20 7920 3150
gelion@tavistock.co.uk

 

Market Abuse Regulation

This announcement contains inside information for the purposes of Article 7 of EU Regulation No. 596/2014, which forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended.

 

About Gelion

Gelion plc (AIM: GELN) is an advanced battery materials company developing next-generation cathode technologies for lithium-ion and lithium-sulfur batteries. Its proprietary Nano-Encapsulated Sulfur (NES™) cathode active material is designed to replace conventional critical-mineral cathodes with abundant sulfur, delivering higher energy density while remaining compatible with existing battery manufacturing infrastructure.

 

The Company's strategy is to commercialise NES™ through partnerships with leading industrial companies and battery manufacturers, enabling adoption within established global supply chains across automotive, defence, device and other high-performance applications. Gelion works with Tier One industrial partners including TDK & Mitsui Kinzoku (Japan), QinetiQ and Nissan (UK), National Laboratory of the Rockies (NLR) (US), and Max Planck Institute of Colloids and Interfaces (MPI) (Germany).

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Gelion (GELN)
UK 100